Clarifies and updates language in the office of state medical examiners statute to address outdated or ambiguous language, outdated practices, outdated position titles/qualifications, and ensure compliance with federal HIPAA requirements.
Provides conditions under which BHDDH has the authority to compel certain healthcare providers to finish requested healthcare records without violating The Health Insurance Portability and Accountability Act.
This bill allows dental hygienists to receive payment from insurance sources other than the dentist's own plan, including third-party payors like Medicare. It directly affects dental practices by expanding the types of insurance that can reimburse dental hygienists for their services. The key provision removes previous restrictions that limited reimbursement to specific insurance arrangements, enabling broader payment options for dental hygiene care. This change applies to all dental practices employing dental hygienists within the state where the bill is enacted.
Requires any licensed lab performing blood lead analyses of a child under 6 to be certified by the director and said laboratory must perform this test regardless of the child or child’s parent’s ability to pay and at no cost.
SB 2032 prohibits health insurance plans in Rhode Island from requiring patients to pay copays, deductibles, or other out-of-pocket costs for diagnostic or supplemental breast examinations. It specifically covers exams used to evaluate abnormalities (diagnostic) or screen for breast cancer in high-risk individuals (supplemental), based on medical history or risk factors. The law applies to all group and individual health insurance plans, including those offered by health maintenance organizations and nonprofit health corporations. The bill takes effect January 1, 2027, ensuring these exams are fully covered without cost-sharing for enrollees.
SB 2444 exempts scalp hair prosthetics or wigs necessary due to medical hair loss from state sales tax. This directly affects individuals with medical conditions requiring such prosthetics, making them more affordable. The bill amends the sales tax code to explicitly include "prosthetic devices" under tax-exempt medical items, aligning with existing exemptions for similar durable medical equipment. The change creates a clear policy update to reduce financial burden for this specific medical need.
SB 2034 requires all health insurance plans sold in the state to cover at least one type of buprenorphine (used for opioid use disorder treatment) without any copayment or deductible for every 12-month plan year. It applies directly to insured individuals in the state who use these insurance plans, starting January 1, 2027. The bill mandates that plans provide this coverage for all forms of buprenorphine administration, eliminating out-of-pocket costs for this medication. Plans may still apply deductibles for health savings account (HSA) pairs, but early implementation before 2027 is permitted.
SB 2010 requires health insurers in Rhode Island to disclose how they use artificial intelligence (AI) to manage claims and coverage decisions, particularly for denials of medically necessary care. Insurers must document AI-driven decisions for five years, report system details to regulators, and ensure licensed healthcare providers review and approve any AI-related denial of medically necessary care before finalizing it. The bill mandates transparency about AI models, training data, and performance metrics, while requiring annual reports to the governor and legislature on insurer AI usage. This directly affects health insurers, enrollees (policyholders), and healthcare providers involved in coverage decisions.
Creates the public health data privacy and protection act to regulate the reporting of information relating to reportable disease data in the possession of the department of health.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.